9 Results

People

  1. Arbour
    Arbour
  2. Drilon
    Drilon
  3. Lai
    Lai
  4. Riely
    Riely
  5. Kris
    Kris
  6. Li
    Li
  7. Offin
    Offin
  8. Hellmann
    Hellmann
  9. Ni
    Ni
  10. Rudin
    Rudin

Groups

  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (9)
  3. Thoracic Oncology (9)
  4. Epidemiology and Biostatistics (7)
  5. Biostatistics Service (6)
  6. GSK Faculty (6)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  8. Human Oncology and Pathogenesis Program (4)
  9. Radiology, Department of (4)
  10. Sloan Kettering Institute Postdocs (4)
  1. "Department of Medicine"
  2. "Alexander Drilon"
  3. "Kathryn Arbour"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (9)
  3. Thoracic Oncology (9)
  4. Epidemiology and Biostatistics (7)
  5. Biostatistics Service (6)
  6. GSK Faculty (6)

More Groups

People
  1. Alexander Drilon (9)
  2. Kathryn Arbour (9)
  3. Gregory Riely (7)
  4. Wei-Chu Lai (7)
  5. Bob Li (6)
  6. Mark Kris (6)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (3)
  6. 2017 (2)
Publications
  1. Annals of Oncology (2)
  2. Journal of Clinical Oncology (2)
  3. Clinical Cancer Research (1)
  4. Cold Spring Harbor Molecular Case Studies (1)
  5. Current Oncology Reports (1)
  6. Nature Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (2)
  2. Oxford University Press (2)
  3. American Association for Cancer Research (1)
  4. Cold Spring Harbor Laboratory Press (1)
  5. Dove Medical Press Ltd (1)
  6. Nature Publishing Group (1)

More Publishers

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • KRAS(G12C) mutation is associated with increased risk of recurrence in surgically resected lung adenocarcinoma
    Journal Article

    Jones, G. D.; Caso, R.; Tan, K. S.; Mastrogiacomo, B.; Sanchez-Vega, F.; Liu, Y.; Connolly, J. G.; Murciano-Goroff, Y. R.; Bott, M. J.; Adusumilli, P. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • COVID-19 in patients with lung cancer
    Journal Article

    Luo, J.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Hoyos, D.; Bandlamudi, C.; McCarthy, C. G.; Falcon, C. J.; Schoenfeld, A. J.; Arbour, K. C.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Exceptional responders with invasive mucinous adenocarcinomas: A phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
    Journal Article

    Drilon, A.; Schoenfeld, A. J.; Arbour, K. C.; Litvak, A.; Ni, A.; Montecalvo, J.; Yu, H. A.; Panora, E.; Ahn, L.; Kennedy, M.; more...
    Cold Spring Harbor Molecular Case Studies (2019)

    Fulltext@MSK | Save
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers
    Meeting Abstract

    Kris, M. G.; Offin, M. D.; Feldman, D. L.; Ni, A.; Lai, W. C. V.; Arbour, K. C.; Daras, M.; Pentsova, E.; DeAngelis, L. M.; Beal, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
    Journal Article

    Sabari, J. K.; Leonardi, G. C.; Shu, C. A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
    Journal Article

    Sabari, J. K.; Santini, F. C.; Schram, A. M.; Bergagnini, I.; Chen, R.; Mrad, C.; Lai, W. V.; Arbour, K. C.; Drilon, A.
    OncoTargets and Therapy (2017)

    Fulltext@MSK | Save
  • Changing the therapeutic landscape in non-small cell lung cancers: The evolution of comprehensive molecular profiling improves access to therapy
    Journal Article

    Sabari, J. K.; Santini, F.; Bergagnini, I.; Lai, W. V.; Arbour, K. C.; Drilon, A.
    Current Oncology Reports (2017)

    Fulltext@MSK | Save